PRESS RELEASE published on 01/29/2025 at 19:03, 1 year 3 months ago AB Science today provides an update on its masitinib platform AB Science provides update on masitinib platform for ALS, MS, and AD. Positive results show potential for huge market sales. Debt negotiation planned Update AB Science Masitinib Platform Market Sales Debt Negotiation
BRIEF published on 01/24/2025 at 18:06, 1 year 3 months ago AB Science to Present Masitinib Update in Upcoming Webcast Pharmaceuticals Webcast Research Update AB Science Masitinib
BRIEF published on 01/24/2025 at 18:06, 1 year 3 months ago AB Science présentera une mise à jour sur le masitinib lors d'un prochain webcast Webcast Médicaments Masitinib Mise À Jour De La Recherche Sciences AB
PRESS RELEASE published on 01/24/2025 at 18:01, 1 year 3 months ago AB Science will host a live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CET AB Science to host live webcast on masitinib platform update on January 28, 2025, 5.30pm CET. Leading pharmaceutical company specializing in protein kinase inhibitors Pharmaceutical Company Live Webcast AB Science Protein Kinase Inhibitors Masitinib Platform
PRESS RELEASE published on 01/24/2025 at 18:01, 1 year 3 months ago AB Science tiendra une conférence virtuelle le mardi 28 janvier 2025, de 17h30 à 18h45 AB Science tiendra une conférence virtuelle le mardi 28 janvier 2025 pour présenter la plateforme masitinib. Des intervenants de renom seront présents. Plus d'informations sur www.ab-science.com Conférence Virtuelle Plateforme AB Science Masitinib Intervenants
BRIEF published on 01/22/2025 at 19:04, 1 year 3 months ago AB Science Participates in Biomed Forum Investors Conference Investor Conference BIOMED Forum AB Science Masitinib Protein Kinase Inhibitors
BRIEF published on 01/22/2025 at 19:04, 1 year 3 months ago AB Science participe à la conférence des investisseurs du Biomed Forum Conférence Des Investisseurs Masitinib Sciences AB Forum Biomédecine Inhibiteurs De La Protéine Kinase
PRESS RELEASE published on 01/22/2025 at 18:59, 1 year 3 months ago AB Science will participate in the Biomed Forum investors conference AB Science to participate in Biomed Forum Investors Conference organized by AllInvest Securities in Paris on February 4, 2025 Pharmaceutical Company BIOMED Forum AB Science Investors Conference AllInvest Securities
PRESS RELEASE published on 01/22/2025 at 18:59, 1 year 3 months ago AB Science participera à la conférence investisseurs Biomed Forum AB Science participera à la conférence investisseurs Biomed Forum à Paris. Présentation de la société pharmaceutique spécialisée dans les IPK. Déclarations prospectives incluses BIOMED Forum Déclarations Prospectives Pharmaceutique AB Science IPK
BRIEF published on 12/17/2024 at 19:09, 1 year 5 months ago AB Science présente les avancées d'AB8939 pour la leucémie aiguë myéloïde Phase 1 AB8939 Leucémie Myéloïde Aiguë Résistance Médicamenteuse Marché Potentiel
Published on 05/21/2026 at 15:00, 4 hours 22 minutes ago Karbon-X Expands Global Energy Attribute Certificate Market Capabilities Amid Growing Renewable Procurement Demand
Published on 05/21/2026 at 14:30, 4 hours 52 minutes ago Rio Grande Resources Advances District-Scale Gold-Silver Target Definition at its Winston Project Through Structural Mapping of Multiple Vein Corridor Systems
Published on 05/21/2026 at 14:00, 5 hours 22 minutes ago Nextech3d.ai to Showcase AI Event Operating System and Krafty Labs Marketplace at Leading EMRG Media Event in New York
Published on 05/21/2026 at 14:00, 5 hours 22 minutes ago Jade Leader Reviews Its Available Critical Minerals Assets
Published on 05/21/2026 at 14:00, 5 hours 22 minutes ago Horizon Aircraft Advances Dual-Use Certification Path Through Cert Center Canada Partnership
Published on 05/21/2026 at 18:26, 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/21/2026 at 18:00, 1 hour 22 minutes ago E-PANGO: Mise en place d’un financement obligataire d’un montant nominal maximum de 4 M€
Published on 05/21/2026 at 17:56, 1 hour 26 minutes ago Annual General Meeting 2026: Adval Tech shareholders approve all proposals
Published on 05/21/2026 at 17:45, 1 hour 37 minutes ago Linedata Services: Assemblée Générale Mixte Modalités de mise à disposition des documents préparatoires
Published on 05/21/2026 at 17:43, 1 hour 39 minutes ago Vonovia SE: AGM approves €1.25 dividend per share and appoints Dr Anne-Marie Großmann-Minkwitz to the Supervisory Board
Published on 05/21/2026 at 17:45, 1 hour 37 minutes ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 05/21/2026 at 17:45, 1 hour 37 minutes ago CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE
Published on 05/21/2026 at 16:35, 2 hours 47 minutes ago 260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
